Pestana José Medina
Hospital do Rim, Fundação Oswaldo Ramos, Division of Nephrology, Universidade Federal de São Paulo.
J Bras Nefrol. 2017 Jul-Sep;39(3):287-295. doi: 10.5935/0101-2800.20170043. Epub 2017 Aug 28.
Kidney transplantation is considered a cost-effective treatment compared to dialysis but accounts for a significant percentage of the public health care resources. Therefore, efficient systems capable of performing high number of procedures are attractive and sustainable.
The aim of this study was to evaluate clinical outcomes of 11,436 kidney transplants regularly performed in a single transplant dedicated center over the last 18 years.
This was a retrospective study performed in a single specialized transplant center. All consecutive patients who underwent transplantation between 08/18/1998 and 12/31/2015 were included in the analysis.
The annual number of transplants increased from 394 in 1999 to 886 in 2015, with a progressive reduction in the proportion of living donor kidney transplants (70% vs. 23%) and yielding over 8869 patients in regular follow up. Of 11,707 kidney transplants performed, 5348 (45.7%) were from living, 3614 (30.9%) standard and 1618 (13.8%) expanded criteria deceased donors, 856 (7.3%) pediatric and 271 (2.3%) simultaneous kidney-pancreas transplants. Comparing 1998-2002 and 2011-2014, five-years graft survival increased for kidney transplants performed with living donors (83.3% vs. 93.1%, p < 0.001), standard deceased donors (60.7% vs. 79.7%, p < 0.001), expanded criteria donors (46.5% vs. 71.5%, p < 0.001) and for the pediatric population (79.8% vs. 80.9%, p = 0.684).
The implementation of a dynamic and efficacious health care system was associated with a progressive increase in the number of kidney transplants, in the cumulative number of patients in follow up and a shift from living related to deceased donor kidney transplants, with associated progressive increase in patient and graft survivals.
与透析相比,肾移植被认为是一种具有成本效益的治疗方法,但却占公共医疗资源的很大比例。因此,能够进行大量手术的高效系统具有吸引力且可持续。
本研究的目的是评估过去18年在一个专门的单一移植中心定期进行的11436例肾移植的临床结果。
这是在一个单一的专业移植中心进行的回顾性研究。分析纳入了1998年8月18日至2015年12月31日期间所有连续接受移植的患者。
移植的年数量从1999年的394例增加到2015年的886例,活体供肾移植的比例逐渐降低(70%对23%),并有超过8869例患者接受定期随访。在进行的11707例肾移植中,5348例(45.7%)来自活体供者,3614例(30.9%)为标准供者,1618例(13.8%)为扩大标准的死亡供者,856例(7.3%)为儿童患者,271例(2.3%)为同期肾-胰腺移植。比较1998 - 2002年和2011 - 2014年,活体供者肾移植、标准死亡供者肾移植、扩大标准供者肾移植以及儿童患者肾移植的五年移植存活率均有所提高(分别为83.3%对93.1%,p < 0.001;60.7%对79.7%,p < 0.001;46.5%对71.5%,p < 0.001;79.8%对80.9%,p = 0.684)。
实施动态且有效的医疗保健系统与肾移植数量的逐渐增加、随访患者累积数量的增加以及从活体亲属供肾移植向死亡供者肾移植的转变相关,同时患者和移植存活率也随之逐渐提高。